Biblio
.
A combinatorial therapeutic approach to enhance FLT3-ITD AML treatment. Cell Rep Med. 2023:101286.
Morroniside Inhibits Inflammatory Bone Loss through the TRAF6-Mediated NF-κB/MAPK Signalling Pathway. Pharmaceuticals (Basel). 2023;16(10).
Sirtuins mediate mitochondrial quality control mechanisms: a novel therapeutic target for osteoporosis. Front Endocrinol (Lausanne). 2023;14:1281213.
. Current status and development trend of miRNAs in osteoporosis-related research: A bibliometric analysis. Folia Histochem Cytobiol. 2021.
.